These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 3468518)

  • 21. Isolation and characterization of an anthracycline-resistant human leukemic cell line.
    Bhalla K; Hindenburg A; Taub RN; Grant S
    Cancer Res; 1985 Aug; 45(8):3657-62. PubMed ID: 3860286
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anthracycline photoaffinity labeling of a mitochondrial polypeptide in P388 murine leukemic cell lines.
    Averbuch SD; Glover CJ; Felsted RL
    Cancer Res; 1986 Dec; 46(12 Pt 1):6120-4. PubMed ID: 3465435
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Active efflux common to vincristine and daunorubicin in vincristine-resistant P388 leukemia.
    Inaba M; Fujikura R; Sakurai Y
    Biochem Pharmacol; 1981 Jul; 30(13):1863-5. PubMed ID: 7271878
    [No Abstract]   [Full Text] [Related]  

  • 24. Modes of resistance to anthracyclines and other natural products.
    Kessel D; Romine M; Decker D
    Prog Clin Biol Res; 1986; 223():81-93. PubMed ID: 3543948
    [No Abstract]   [Full Text] [Related]  

  • 25. Pharmacodynamic aspects of aclarubicin with special reference to daunorubicin and doxorubicin.
    Skovsgaard T
    Eur J Haematol Suppl; 1987; 47():7-20. PubMed ID: 3552720
    [No Abstract]   [Full Text] [Related]  

  • 26. [Reversal of acquired resistance to vinca alkaloids and anthracycline antibiotics by calcium channel blockers and calmodulin inhibitors].
    Tsuruo T
    Gan To Kagaku Ryoho; 1984 Mar; 11(3 Pt 2):750-9. PubMed ID: 6585181
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Promotion of daunorubicin uptake and toxicity by the calcium antagonist tiapamil and its analogs.
    Kessel D; Wilberding C
    Cancer Treat Rep; 1985 Jun; 69(6):673-6. PubMed ID: 4016770
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interactions among membrane transport systems: anthracyclines, calcium antagonists and anti-estrogens.
    Kessel D
    Biochem Pharmacol; 1986 Aug; 35(16):2825-6. PubMed ID: 2943288
    [No Abstract]   [Full Text] [Related]  

  • 29. o-Methylation on anthracyclines and anthracyclinones. New o-methyl ethers of daunorubicin and its analogues.
    Cassinelli G; Di Matteo F; Forenza S; Ripamonti MC; Ruggieri D; Vigevani A; Arcamone F
    Farmaco Sci; 1982 Aug; 37(8):501-13. PubMed ID: 6957317
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Flow cytometric monitoring of anthracycline transport in tumor cells.
    Krishan A
    Ann N Y Acad Sci; 1986; 468():80-4. PubMed ID: 3460483
    [No Abstract]   [Full Text] [Related]  

  • 31. Difference between the resistance mechanisms of aclacinomycin- and adriamycin-resistant P388 cell lines.
    Dong J; Naito M; Tatsuta T; Seimiya H; Johdo O; Tsuruo T
    Oncol Res; 1995; 7(5):245-52. PubMed ID: 8534930
    [TBL] [Abstract][Full Text] [Related]  

  • 32. m-AMSA as a probe for transport phenomena associated with anthracycline resistance.
    Kessel D; Wheeler C
    Biochem Pharmacol; 1984 Apr; 33(7):991-3. PubMed ID: 6585205
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanism of resistance to anthracyclines and vinca alkaloids.
    Danø K; Skovsgaard T; Nissen NI; Friche E; Di Marco A
    Prog Clin Biol Res; 1983; 132C():231-46. PubMed ID: 6579564
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Features of developing resistance during combined use of antineoplastic agents, causing multiple drug resistance].
    Goncharova SA; Demidova NS; Shiriaeva OA; Konovalova NP
    Dokl Akad Nauk SSSR; 1991; 319(4):985-8. PubMed ID: 1800074
    [No Abstract]   [Full Text] [Related]  

  • 35. Production of new anthracycline antibiotics 1-hydroxy-oxaunomycin and 6-deoxyoxaunomycin by limited biosynthetic conversion using a daunorubicin-negative mutant.
    Yoshimoto A; Johdo O; Tone H; Okamoto R; Naganawa H; Sawa T; Takeuchi T
    J Antibiot (Tokyo); 1992 Oct; 45(10):1609-17. PubMed ID: 1473988
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A new antitumor antibiotic, carminomycin (NSC-180024).
    Gause GF; Brazhnikova MG; Shorin VA
    Cancer Chemother Rep; 1974; 58(2):255-6. PubMed ID: 4830498
    [No Abstract]   [Full Text] [Related]  

  • 37. 13-Deoxycarminomycin, a new biosynthetic anthracycline.
    Cassinelli G; Forenza S; Rivola G; Arcamone F; Grein A; Merli S; Casazza AM
    J Nat Prod; 1985; 48(3):435-9. PubMed ID: 3861771
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Distribution and metabolism of adriamycin in mice. Comparison with daunomycin.
    Di Fronzo G; Gambetta RA; Lenaz L
    Rev Eur Etud Clin Biol; 1971; 16(6):572-6. PubMed ID: 5125106
    [No Abstract]   [Full Text] [Related]  

  • 39. [Studies on the mechanism of drug resistance in tumor cells and a new antitumor antibiotic].
    Tanaka N
    Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2666-73. PubMed ID: 6210060
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Correlations between anthracycline resistance, drug accumulation and membrane glycoprotein patterns in solid tumors of mice.
    Kessel D; Corbett T
    Cancer Lett; 1985 Sep; 28(2):187-93. PubMed ID: 3863701
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.